000 01473 a2200445 4500
005 20250518062219.0
264 0 _c20200228
008 202002s 0 0 eng d
022 _a1528-0020
024 7 _a10.1182/blood.2019002258
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChong, Elise A
245 0 0 _aCAR T cell viability release testing and clinical outcomes: is there a lower limit?
_h[electronic resource]
260 _bBlood
_c11 2019
300 _a1873-1875 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aCell Survival
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
_xstandards
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xmortality
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xmortality
650 0 4 _aReceptors, Antigen, T-Cell
_xtherapeutic use
650 0 4 _aReceptors, Chimeric Antigen
650 0 4 _aT-Lymphocytes
650 0 4 _aTreatment Outcome
700 1 _aLevine, Bruce L
700 1 _aGrupp, Stephan A
700 1 _aDavis, Megan M
700 1 _aSiegel, Don L
700 1 _aMaude, Shannon L
700 1 _aGladney, Whitney L
700 1 _aFrey, Noelle V
700 1 _aPorter, David L
700 1 _aHwang, Wei-Ting
700 1 _aChong, Emeline R
700 1 _aJune, Carl H
700 1 _aSchuster, Stephen J
773 0 _tBlood
_gvol. 134
_gno. 21
_gp. 1873-1875
856 4 0 _uhttps://doi.org/10.1182/blood.2019002258
_zAvailable from publisher's website
999 _c30144919
_d30144919